本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Monopar Therapeutics

39.42
-2.9500-6.96%
盤後39.420.00000.00%17:09 EDT
成交量:4.85萬
成交額:200.98萬
市值:2.41億
市盈率:-9.59
高:43.85
開:41.89
低:39.01
收:42.37
資料載入中...
2019/11/05

SEC問詢函

[Cover]Correspondence
2019/11/04

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/11/04

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/10/02

SEC問詢函

[Cover]Correspondence
2019/10/02

SEC問詢函

[Cover]Correspondence
2019/10/01

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/09/30

SEC問詢函

[Cover]Correspondence
2019/09/23

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/09/13

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/09/10

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/08/15

招股説明書

General form for registration of securities under the Securities Act of 1933
2019/08/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/06/27

重要事件披露

Current report, item 5.07
2019/05/10

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/02/26

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2018/12/11

SEC問詢函

[Cover]Correspondence
2018/12/11

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2018/12/11

[修訂]季度報告

[Amend] Quarterly report [Sections 13 or 15(d)]
2018/12/11

[修訂]季度報告

[Amend] Quarterly report [Sections 13 or 15(d)]
2018/12/11

[修訂]季度報告

[Amend] Quarterly report [Sections 13 or 15(d)]